
Amgen's experimental Sjogren's drug meets late-stage trial goal
来源:Reuters发布于 2026-11-11
Amgen said on Wednesday its experimental drug showed sustained reduction in disease activity in a late-stage study of patients with Sjogren's disease, an autoimmune condition.
相关标的:AMGN
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。